LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Search

Lisata Therapeutics

Cerrado

1.99 -1.49

Resumen

Variación precio

24h

Actual

Mínimo

1.8599999999999999

Máximo

2.02

Métricas clave

By Trading Economics

Empleados

26

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+617.7% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-4.5M

16M

Apertura anterior

3.48

Cierre anterior

1.99

Lisata Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

18 nov 2025, 19:25 UTC

Adquisiciones, fusiones, absorciones

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18 nov 2025, 18:09 UTC

Adquisiciones, fusiones, absorciones

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18 nov 2025, 17:39 UTC

Adquisiciones, fusiones, absorciones

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18 nov 2025, 16:25 UTC

Principales Movimientos del Mercado

Diginex Rises on Deal With Digital Asset Platform Evident

18 nov 2025, 23:56 UTC

Charlas de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18 nov 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18 nov 2025, 22:59 UTC

Charlas de Mercado

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18 nov 2025, 22:08 UTC

Charlas de Mercado

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18 nov 2025, 22:03 UTC

Adquisiciones, fusiones, absorciones

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18 nov 2025, 22:03 UTC

Ganancias

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18 nov 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

18 nov 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

18 nov 2025, 21:15 UTC

Charlas de Mercado

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18 nov 2025, 20:46 UTC

Charlas de Mercado

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18 nov 2025, 20:13 UTC

Charlas de Mercado

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18 nov 2025, 19:48 UTC

Charlas de Mercado

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18 nov 2025, 19:19 UTC

Adquisiciones, fusiones, absorciones

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18 nov 2025, 18:29 UTC

Ganancias

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18 nov 2025, 18:18 UTC

Charlas de Mercado

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18 nov 2025, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

18 nov 2025, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

18 nov 2025, 17:19 UTC

Charlas de Mercado
Ganancias

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18 nov 2025, 17:06 UTC

Ganancias

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18 nov 2025, 16:06 UTC

Adquisiciones, fusiones, absorciones

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18 nov 2025, 15:59 UTC

Ganancias

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18 nov 2025, 15:35 UTC

Adquisiciones, fusiones, absorciones

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18 nov 2025, 15:35 UTC

Adquisiciones, fusiones, absorciones

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Comparación entre iguales

Cambio de precio

Lisata Therapeutics Esperado

Precio Objetivo

By TipRanks

617.7% repunte

Estimación a 12 meses

Media 15 USD  617.7%

Máximo 15 USD

Mínimo 15 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Lisata Therapeutics Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Finanzas

$

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
help-icon Live chat